FDA Expects To Act On New Drug Safety Cooperative Agreements By Sept. 30
Executive Summary
FDA intends to sign new contracts that will provide the agency access to population-based data resources through its cooperative agreement program by Sept. 30
You may also be interested in...
FDA Postmarketing Surveillance System Adds Kaiser Retrospective Database
FDA will have access to four population-based databases for safety surveillance through its cooperative agreement program beginning in FY 2006, including the newly added Kaiser Permanente California registry
FDA Postmarketing Surveillance System Adds Kaiser Retrospective Database
FDA will have access to four population-based databases for safety surveillance through its cooperative agreement program beginning in FY 2006, including the newly added Kaiser Permanente California registry
FDA Review Of Fertility Drug Use For Safety Signals To Use IMS Data
FDA's Office of Drug Safety is conducting a nationwide analysis of the use of fertility drugs as a basis for an evaluation of post-marketing safety issues with fertility treatments